About Medartis
Medartis is a publicly listed company based in Basel (Switzerland) founded in 1997. Metal implants for orthopedic fracture fixation are developed and marketed. The company has 949 employees. Medartis has completed 3 acquisitions, including Keri Medical, MIMEDIS and Nextremity Solutions. Its website medartis.com draws about 43 thousand monthly visits. Medartis offers products and services including MODUS 2 Midface, APTUS Hand System, and Distal Radius System. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is MEDARTIS LIMITED.
Company details
Medartis develops and markets metal implants for the surgical fixation of fractures and osteotomies. The company offers the Aptus range of products for Hand, Wrist, Elbow, and Foot; and the MODUS range of products for Cranium, Midface, and Mandible. The products include fixation systems for the management of fractures, radius fixation, distal radius, arthrodesis systems, dorsal frame, distal ulna, wrist plates, screws, etc. The products are distributed across the globe through distributors. Headquartered in Switzerland, the company also has subsidiaries in Austria, France, the United Kingdom, Germany, Poland, the United States, Mexico, Spain, Australia, and New Zealand.
- Annual Revenue$339.68 M (USD)19.76as on Dec 31, 2025
- Net Profit$10.53 M (USD)136.65as on Dec 31, 2025
- EBITDA$32.32 M (USD)-27.28as on Dec 31, 2025
- Employee Count949
- Investments & AcquisitionsKeri Medical
& 2 more
Products & Services of Medartis
Medartis offers a comprehensive portfolio of products and services, including MODUS 2 Midface, APTUS Hand System, and Distal Radius System.
Provides fixation for midface fractures in orthopedic procedures.
Supports hand fracture osteosynthesis and reconstructions.
Enables correction of wrist fractures and osteotomies.
Apps and channels of Medartis
its YouTube channel Medartis has 2.98K subscribers and 30 videos.
Videos from Medartis
The most watched videos on Medartis's YouTube channel, Medartis (2.98K subscribers). Click a video to play it here.
More on Medartis.
People of Medartis
65 people are tracked at Medartis (24 in leadership, 7 in board & advisors, 34 in team); the tracked headcount is 949.
| Name | Role | Group |
|---|---|---|
Peter Cologna | Head Of Education | Leadership |
Claudia de Santis | Director Global Ra, QM & PLM | Leadership |
Mareike Loch | VP, EMEA | Leadership |
Dirk Kirsten | Group CFO / Member Of Executive Management Board | Leadership |
Mario Della Casa | COO | Leadership |
Manuel Schaer | CTO | Leadership |
Christoph Brönnimann | CEO | Leadership |
Matthias Klinger | Area Sales Director North | Leadership |
Marc Ammann | Executive Vice President R&d And Innovation | Leadership |
Jennifer B. | VP Of Finance | Leadership |
James Jencarelli | Director Of Finance | Leadership |
Jared Herscovitz | Head Of Sales - UK | Leadership |
Loïc Vanherck | Commercial Vice President - Keri Medical | Leadership |
Frederico Rinke | HR Director Latam & Transition Leader | Leadership |
Reto Schmitt | Head Of Technical Finance & External Reporting | Leadership |
Thomas Hanselmann | Head IT Applications | Leadership |
Tanner Jacobs | Vice President Of Sales | Leadership |
Santiago Trujillo | General Manager Mexico & Distribution Latam | Leadership |
Caroline Knoeri | Chief Human Resources Officer, Member Of The Executive Board | Leadership |
Steve Rudolf | Director Of Sales, Western Region | Leadership |
45 more people are available in the full profile.
Complete people profiles for Medartis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Medartis
Medartis is a publicly listed company on the SIX with ticker symbol MED in Switzerland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date23 Mar 2018
- Listed onBX: MED
- Listed entityMedartis Holding AG
- Exchange sectorHealth technology
- ISINCH0386200239
- Share price77.00 CHF (+0.13% on the day) · 2026-05-11
- Market capitalisation1,048,343,208.00 CHF
- Price to earnings114.8
- EPS (diluted, trailing year)0.67 CHF
- Volume (last session)2,770
- Analyst consensusBuy
Financials of Medartis
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 269.3M CHF | 8.3M CHF | 25.6M CHF |
| 2024 | 224.8M CHF | 3.5M CHF | 35.2M CHF |
| 2023 | 212.0M CHF | 619,000 CHF | 32.4M CHF |
| 2022 | 182.8M CHF | -5.8M CHF | 16.2M CHF |
| 2021 | 159.9M CHF | 6.8M CHF | 27.4M CHF |
Detailed financial statements for Medartis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medartis
Medartis has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Keri Medical, MIMEDIS and Nextremity Solutions.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Hand and wrist surgery medical devices are developed and manufactured. | kerimedical.com | Geneva, Switzerland | 2017 | Jul 2025 | $123M | |
Extremity musculoskeletal orthopedic products are developed and customized. | nextremity.com | Warsaw, United States | 2006 | Mar 2022 | •••• | |
Patient-specific bone implants are developed for cranio-maxillofacial applications. | mimedis.com | Basel, Switzerland | 2013 | Jul 2017 | •••• |
Complete acquisition details for Medartis
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Medartis
5 dated milestones of Medartis across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Medartis is founded.
- Acquisition Acquires MIMEDIS.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Nextremity Solutions.
- Acquisition Acquires Keri Medical.
Web traffic of Medartis
The website of Medartis (medartis.com) receives about 42.8K visits a month.
- Monthly visits42.8K
▲ 12.2% vs previous month
Websites whose visitors overlap most with Medartis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
synthes.com | synthes.com | 100% | #12,897,470 | – | |
laneshearing.co.uk | laneshearing.co.uk | 96% | – | ||
giuseppefanzone.it | giuseppefanzone.it | 95% | #6,394,122 | – | |
revmedconnect.com | revmedconnect.com | 95% | #771,336 | – | |
werkomed.co.za | werkomed.co.za | 93% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Medartis
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medartis
Complete news archive for Medartis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medartis
Medartis was founded in 1997.
Medartis is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Medartis has 949 employees.
Annual revenue of Medartis is $339.68M as on Dec 31, 2025.
Medartis develops and markets metal implants for the surgical fixation of fractures and osteotomies. The company offers the Aptus range of products for Hand, Wrist, Elbow, and Foot; and the MODUS range of products for Cranium, Midface, and Mandible. The products include fixation systems for the management of fractures, radius fixation, distal radius, arthrodesis systems, dorsal frame, distal ulna, wrist plates, screws, etc. The products are distributed across the globe through distributors. Headquartered in Switzerland, the company also has subsidiaries in Austria, France, the United Kingdom, Germany, Poland, the United States, Mexico, Spain, Australia, and New Zealand.
Medartis offers MODUS 2 Midface, APTUS Hand System, and Distal Radius System.
Yes, Medartis is publicly traded on SIX under the ticker symbol MED.
Medartis has made 3 acquisitions, including Keri Medical, MIMEDIS, and Nextremity Solutions.
Medartis operates through Medartis Limited.